معرفی
Cory Brooks is a Professor in the Department of Chemistry and Biochemistry at California State University, Fresno. He holds a Ph.D. in antibody structural biology from the University of Victoria (2005-2010) and completed postdoctoral research in membrane protein structural biology at the University of Alberta (2010-2013). His research focuses on structural biology applications for antibody-antigen interactions, particularly in cancer immunotherapy and biotechnology. He teaches courses such as CHEM 150, CHEM 155A, and CHEM 3B, emphasizing biochemistry education.
Research Interests: His lab uses X-ray crystallography to study antibody structures, aiming to engineer next-generation antibody drugs targeting cancer and infectious diseases. Key projects include MUC16 antigen recognition, theranostic antibody development, and glycoprotein interactions. Notable areas include pancreatic and ovarian cancer immunotherapy, antibody contrast agents, and nanobody applications.
Articles Trends: Recent work emphasizes MUC16-targeted therapies, AI-driven antibody design, and structural insights into antibody-antigen complexes. His 2025 studies highlight advancements in pretargeted alpha therapy and antibody-conjugated imaging agents.
Scientific Awards: No awards explicitly mentioned in the text.
Advising & Grants: While no advisees are listed, his teaching includes advanced biochemistry and research methods. Grant details are not specified here.
Labs/Teams: Leads the Brooks Research Group, dedicated to structural biology and antibody engineering innovations.
